Clinical trials recruiting in Nigeria

Phase breakdown

Cities in Nigeria

Conditions recruiting in Nigeria

Recruiting trials in Nigeria

• A Combination Triple Pill Implementation Strategy for Blood Pressure cONtrol
  NCT07784647 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• A Comparative Study of Intraocular Pressure Control Using Selective Laser Trabeculoplasty and Latanoprost as Initial Treatments for Primary Open Angle Glaucoma and Ocular Hypertension in Lagos State University Teaching Hospital
  NCT07310719 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: All (male and female)
• A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
  NCT05953584 · Phase: Phase 2 · Ages: 12 Years to 16 Years · Sex: All (male and female)
• A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
  NCT05431088 · Phase: Phase 2, Phase 3 · Ages: 12 Years and older · Sex: All (male and female)
• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
  NCT06609226 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female)
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
  NCT06612268 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female)
• A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease
  NCT06198712 · Phase: Phase 2 · Ages: 6 Months to 18 Years · Sex: All (male and female)
• A Study to Find and Confirm Blood-based Markers (Called Proteins) That May Show Early Heart Changes in Women With Preeclampsia, Even Before Symptoms Appear, and the Use of Heart Ultrasound (Echocardiography) to Look at Patterns of How the Heart Changes During Pregnancy in Women With Preeclampsia
  NCT07463898 · Phase: Not specified · Ages: 13 Years to 50 Years · Sex: Female
• ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
  NCT06128304 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 64 Years · Sex: Female
• Addressing Hypertension Care in Africa Program
  NCT06986590 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female)
• Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
  NCT06348134 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female
• Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria
  NCT05044689 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• Change My Story Task Shifted Mental Health Intervention
  NCT06389565 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 29 Years · Sex: All (male and female)
• Combination Intervention to Enhance Treatment Engagement and Viral Suppression Among Sexual and Gender Minority Youth in Nigeria
  NCT06190613 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 29 Years · Sex: Male
• Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria
  NCT06751030 · Phase: Not specified · Ages: 25 Years to 50 Years · Sex: Female
• Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
  NCT05069688 · Phase: Phase 1 · Ages: 4 Weeks to 5 Years · Sex: All (male and female)
• Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention
  NCT06281834 · Phase: Phase 1 · Ages: 4 Weeks to 11 Years · Sex: All (male and female)
• Effect of Metformin Use on Weight Loss in Obese, Non-diabetic People (MOWRI)
  NCT07297290 · Phase: Phase 3 · Ages: 20 Years to 59 Years · Sex: All (male and female)
• Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care
  NCT06630962 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria
  NCT06859359 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: Female
• Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness/Implementation Hybrid Study
  NCT06880224 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 24 Years · Sex: All (male and female)
• International Registry for Men With Advanced Prostate Cancer (IRONMAN)
  NCT03151629 · Phase: Not specified · Ages: 21 Years and older · Sex: Male
• MicroRNA Profiles in Triple Negative Breast Cancer
  NCT04771871 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female
• PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
  NCT04477785 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female)
• Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)
  NCT04874038 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female)
• Protocol RV 583 Multinational Observational Cohort of HIV and Other Infections
  NCT05147519 · Phase: Not specified · Ages: 14 Years to 55 Years · Sex: All (male and female)
• Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study
  NCT05164263 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)
  NCT05580666 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Stroke Prevention in Nigeria 2 Trial
  NCT06526117 · Phase: Phase 4 · Ages: 5 Years to 12 Years · Sex: All (male and female)
• Study of the Role of Genetic Modifiers in Hemoglobinopathies
  NCT05799118 · Phase: Not specified · Ages: 2 Years and older · Sex: All (male and female)
• Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
  NCT05561842 · Phase: Not specified · Ages: 18 Years and older · Sex: Female
• The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
  NCT06717295 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female)
• The Ibadan Acute and Chronic Heart Failure Project
  NCT05936957 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
• Tislelizumab in People With Colorectal Cancer
  NCT06529523 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
  NCT06291064 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female
• iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
  NCT03549754 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• mAnaging siCkle CELl disEase Through incReased AdopTion of hydroxyurEa in Nigeria
  NCT06318143 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Months and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Nigeria?

37 recruiting trials have at least one study site in Nigeria.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.